HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,406 | +10.2% | 3,340 | -2.1% | 0.01% | +7.7% |
| Q2 2023 | $350,720 | -16.1% | 3,410 | -11.0% | 0.01% | -7.1% |
| Q1 2023 | $418,008 | -8.0% | 3,830 | -4.1% | 0.01% | -12.5% |
| Q4 2022 | $454,497 | +45.7% | 3,993 | -20.9% | 0.02% | +33.3% |
| Q3 2022 | $312,000 | -22.8% | 5,048 | -0.4% | 0.01% | -14.3% |
| Q2 2022 | $404,000 | -27.6% | 5,069 | -4.4% | 0.01% | -17.6% |
| Q1 2022 | $558,000 | -14.3% | 5,301 | -12.3% | 0.02% | -5.6% |
| Q4 2021 | $651,000 | -8.2% | 6,044 | -6.6% | 0.02% | -14.3% |
| Q3 2021 | $709,000 | +5.7% | 6,470 | -9.7% | 0.02% | +5.0% |
| Q2 2021 | $671,000 | -1.0% | 7,163 | -2.8% | 0.02% | -9.1% |
| Q1 2021 | $678,000 | +31.9% | 7,366 | +4.8% | 0.02% | +29.4% |
| Q4 2020 | $514,000 | -49.0% | 7,027 | -45.8% | 0.02% | -57.5% |
| Q3 2020 | $1,007,000 | +280.0% | 12,965 | +172.3% | 0.04% | +233.3% |
| Q2 2020 | $265,000 | – | 4,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |